Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
1 Jun 2021	Submitted	Original manuscript
7 Jun 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
9 Jun 2021	Editorially accepted
6 Jul 2021	Article published	10.1186/s13063-021-05363-w

Back to article page